SAA1 is highly expressed in lung cancer, gastric cancer, endometrial cancer, prostate cancer, melanoma, and esophagus cancer, which presented poor prognosis in patients (12, 13, 15, 19, 33, 34). Here, SAA1 is linked to lung cancer.